Search by Drug Name or NDC

    NDC 00006-4093-09 RECOMBIVAX HB 5 ug/.5mL Details

    RECOMBIVAX HB 5 ug/.5mL

    RECOMBIVAX HB is a INTRAMUSCULAR; SUBCUTANEOUS INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN.

    Product Information

    NDC 00006-4093
    Product ID 0006-4093_30c061ac-552c-48bc-83fa-95b10e9fc1ee
    Associated GPIs 17100010201815
    GCN Sequence Number 062709
    GCN Sequence Number Description hepatitis B virus vaccine/PF SYRINGE 5MCG/0.5ML INTRAMUSC
    HIC3 W7B
    HIC3 Description VIRAL/TUMORIGENIC VACCINES
    GCN 98483
    HICL Sequence Number 034649
    HICL Sequence Number Description HEPATITIS B VIRUS VACCINE RECOMBINANT/PF
    Brand/Generic Brand
    Proprietary Name RECOMBIVAX HB
    Proprietary Name Suffix n/a
    Non-Proprietary Name Hepatitis B Vaccine (Recombinant)
    Product Type VACCINE
    Dosage Form INJECTION, SUSPENSION
    Route INTRAMUSCULAR; SUBCUTANEOUS
    Active Ingredient Strength 5
    Active Ingredient Units ug/.5mL
    Substance Name HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA101066
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-4093-09 (00006409309)

    NDC Package Code 0006-4093-09
    Billing NDC 00006409309
    Package 6 SYRINGE in 1 CARTON (0006-4093-09) / .5 mL in 1 SYRINGE (0006-4093-01)
    Marketing Start Date 1986-07-23
    NDC Exclude Flag N
    Pricing Information N/A